Search criteria

2 vulnerabilities found for Oracle Life Sciences Central Coding by Oracle Corporation

CVE-2026-21980 (GCVE-0-2026-21980)

Vulnerability from nvd – Published: 2026-01-20 21:56 – Updated: 2026-01-21 17:00
VLAI?
Summary
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CWE
  • Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data.
Assigner
References
Impacted products
Show details on NVD website

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-21980",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "yes"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-01-21T16:50:20.352960Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "description": "CWE-noinfo Not enough information",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-01-21T17:00:43.202Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Oracle Life Sciences Central Coding",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "status": "affected",
              "version": "7.0.1.0",
              "versionType": "semver"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:life_sciences_central_coding:7.0.1.0:*:*:*:*:*:*:*",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "confidentialityImpact": "LOW",
            "integrityImpact": "LOW",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-01-20T21:56:38.638Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpujan2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-21980",
    "datePublished": "2026-01-20T21:56:38.638Z",
    "dateReserved": "2026-01-05T18:07:34.716Z",
    "dateUpdated": "2026-01-21T17:00:43.202Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}

CVE-2026-21980 (GCVE-0-2026-21980)

Vulnerability from cvelistv5 – Published: 2026-01-20 21:56 – Updated: 2026-01-21 17:00
VLAI?
Summary
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CWE
  • Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data.
Assigner
References
Impacted products
Show details on NVD website

{
  "containers": {
    "adp": [
      {
        "metrics": [
          {
            "other": {
              "content": {
                "id": "CVE-2026-21980",
                "options": [
                  {
                    "Exploitation": "none"
                  },
                  {
                    "Automatable": "yes"
                  },
                  {
                    "Technical Impact": "partial"
                  }
                ],
                "role": "CISA Coordinator",
                "timestamp": "2026-01-21T16:50:20.352960Z",
                "version": "2.0.3"
              },
              "type": "ssvc"
            }
          }
        ],
        "problemTypes": [
          {
            "descriptions": [
              {
                "description": "CWE-noinfo Not enough information",
                "lang": "en",
                "type": "CWE"
              }
            ]
          }
        ],
        "providerMetadata": {
          "dateUpdated": "2026-01-21T17:00:43.202Z",
          "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
          "shortName": "CISA-ADP"
        },
        "title": "CISA ADP Vulnrichment"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Oracle Life Sciences Central Coding",
          "vendor": "Oracle Corporation",
          "versions": [
            {
              "status": "affected",
              "version": "7.0.1.0",
              "versionType": "semver"
            }
          ]
        }
      ],
      "cpeApplicability": [
        {
          "nodes": [
            {
              "cpeMatch": [
                {
                  "criteria": "cpe:2.3:a:oracle:life_sciences_central_coding:7.0.1.0:*:*:*:*:*:*:*",
                  "vulnerable": true
                }
              ],
              "negate": false,
              "operator": "OR"
            }
          ]
        }
      ],
      "descriptions": [
        {
          "lang": "en-US",
          "value": "Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N)."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "confidentialityImpact": "LOW",
            "integrityImpact": "LOW",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N",
            "version": "3.1"
          }
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "description": "Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data.",
              "lang": "en-US"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-01-20T21:56:38.638Z",
        "orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
        "shortName": "oracle"
      },
      "references": [
        {
          "name": "Oracle Advisory",
          "tags": [
            "vendor-advisory"
          ],
          "url": "https://www.oracle.com/security-alerts/cpujan2026.html"
        }
      ]
    }
  },
  "cveMetadata": {
    "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
    "assignerShortName": "oracle",
    "cveId": "CVE-2026-21980",
    "datePublished": "2026-01-20T21:56:38.638Z",
    "dateReserved": "2026-01-05T18:07:34.716Z",
    "dateUpdated": "2026-01-21T17:00:43.202Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}